The incretin mimetic, exenatide: a novel treatment option for type 2 diabetes.

MLA

Schnabel, Catherine A. “The Incretin Mimetic, Exenatide: A Novel Treatment Option for Type 2 Diabetes.” British Journal of Diabetes & Vascular Disease, vol. 5, no. 4, July 2005, pp. 227–35. EBSCOhost, https://doi.org/10.1177/14746514050050040801.

APA

Schnabel, C. A. (2005). The incretin mimetic, exenatide: a novel treatment option for type 2 diabetes. British Journal of Diabetes & Vascular Disease, 5(4), 227–235. https://doi.org/10.1177/14746514050050040801

Chicago

Schnabel, Catherine A. 2005. “The Incretin Mimetic, Exenatide: A Novel Treatment Option for Type 2 Diabetes.” British Journal of Diabetes & Vascular Disease 5 (4): 227–35. doi:10.1177/14746514050050040801.